WILLIAM DEMANT/ADR (OTCMKTS:WILYY) Rating Lowered to Sell at Zacks Investment Research

WILLIAM DEMANT/ADR (OTCMKTS:WILYY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Thursday, September 20th.

According to Zacks, “William Demant Holding A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Company focuses on three business areas: Hearing Devices, Diagnostic Instruments and Personal Communication. William Demant Holding A/S is headquartered in Smorum, Denmark. “

Shares of WILYY stock traded up $0.50 during trading hours on Thursday, reaching $16.55. 504 shares of the company’s stock were exchanged, compared to its average volume of 362. The company has a market cap of $10.62 billion, a price-to-earnings ratio of 31.83, a price-to-earnings-growth ratio of 2.79 and a beta of 0.50. WILLIAM DEMANT/ADR has a 1 year low of $13.47 and a 1 year high of $23.90.


William Demant Holding A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment designed to aid the people with hearing loss connect and communication primarily in Denmark, rest of Europe, North America, Oceania, Asia, and other countries. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments.

Featured Story: What is Considered a Good Return on Equity (ROE)?

Get a free copy of the Zacks research report on WILLIAM DEMANT/ADR (WILYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for WILLIAM DEMANT/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WILLIAM DEMANT/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply